Novel Immunotherapy for Primary Hemophagocytic Lymphohistiocytosis

Results of a study evaluating the safety and efficacy of a promising new agent were presented at ASH 2018.

Source: CancerNetwork - December 7, 2018 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news